Nephrolithiasis and hypertension: possible links and clinical implications

Area of Science:

• Nephrology
• Cardiology
• Metabolic Diseases

Background:

• Kidney stone disease (nephrolithiasis) shows a clear epidemiological link with arterial hypertension.
• Pathophysiological mechanisms remain unclear, with hypercalciuria, inflammation, and oxidative stress as proposed factors.
• The association is increasingly viewed within the context of metabolic syndrome and atherosclerosis.

Purpose of the Study:

• To highlight the clinical significance of the nephrolithiasis-hypertension association.
• To advocate for a comprehensive management approach for kidney stone patients.
• To emphasize viewing kidney stone disease as a systemic disorder.

Main Methods:

• Review of epidemiological and pathophysiological evidence linking kidney stone disease and hypertension.
• Analysis of clinical management implications.
• Synthesis of current understanding of systemic associations.

Main Results:

• Strong epidemiological evidence supports the association between kidney stones and hypertension.
• Metabolic syndrome and atherosclerosis are key components of this association.
• Kidney stone disease is linked to chronic kidney disease, bone damage, and cardiovascular issues.

Conclusions:

• Physicians should assess cardiovascular risk factors in all adult kidney stone patients.
• Management should extend beyond urinary tract interventions to address systemic implications.
• Treating kidney stone disease as a systemic disorder can improve patient prognosis and clinical outcomes.